Skip to Content Skip to Content

Immunology

Pursuing vaccines to stop celiac disease
A researcher holding a vaccine vial in a lab next to a microscope.

Image: iStock/nuttapong punna

Pursuing vaccines to stop celiac disease

Scientists at Penn’s Institute for RNA Innovation are using messenger RNA to stop the immune response that triggers celiac disease symptoms.

Alex Gardner

No evidence that CAR T cell therapy causes secondary cancers
Person in gloves holding a medical bag of liquids.

Image: Courtesy of Penn Medicine

No evidence that CAR T cell therapy causes secondary cancers

In a new study, researchers at Penn Medicine looked for—and did not find—examples where the process of generating CAR T cells caused malignancy.

Kelsey Geesler

The compassionate team behind CAR T cancer breakthroughs
From left, research coordinator Nicolas Sarmiento, project manager Reenie Martins, research coordinator Lee Dengel, and trial sample coordinator Rutendo Manyeka in a hospital.

(From left) Research coordinator Nicolas Sarmiento, project manager Reenie Martins, research coordinator Lee Dengel, and trial sample coordinator Rutendo Manyeka document and prepare paperwork required for T-cell infusion.

(Image: Courtesy of Penn Medicine News)

The compassionate team behind CAR T cancer breakthroughs

The clinical trial support staff at Penn Medicine and the Abramson Cancer Center have helped execute the team science that brings research discoveries from the lab bench to the bedside.

From Penn Medicine News